Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4 - Wikidata - awgldk - TriplyDB

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

http://www.wikidata.org/entity/Q22254704

about

Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways The functional genomic response of developing embryonic submandibular glands to NF-kappa B inhibition The life cycle of chondrocytes in the developing skeleton.Fibroblast Growth Factor Signaling in Metabolic Regulation Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers The 1.65 Å resolution structure of the complex of AZD4547 with the kinase domain of FGFR1 displays exquisite molecular recognition PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.Genetic insights into the mechanisms of Fgf signaling Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias Exposure to organophosphates reduces the expression of neurotrophic factors in neonatal rat brain regions: similarities and differences in the effects of chlorpyrifos and diazinon on the fibroblast growth factor superfamily Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation Preclinical studies of fibroblast growth factor receptor 3 as a therapeutic target in multiple myeloma DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis A place for precision medicine in bladder cancer: targeting the FGFRs.Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.ESCRT-II/Vps25 constrains digit number by endosome-mediated selective modulation of FGF-SHH signaling.Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas.Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?The receptor tyrosine kinase FGFR4 negatively regulates NF-kappaB signaling.The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancer Gene disruption of Spred-2 causes dwarfism.The Fibroblast Growth Factor signaling pathway Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).Fibroblast growth factors in cancer: therapeutic possibilities.Role of genetic polymorphisms in tumour angiogenesis PLZF regulates fibroblast growth factor responsiveness and maintenance of neural progenitors.Fibroblast growth factor blocks Sonic hedgehog signaling in neuronal precursors and tumor cells.Replacement of E-cadherin by N-cadherin in the mammary gland leads to fibrocystic changes and tumor formation.Anti-Angiogenic Properties of BDDPM, a Bromophenol from Marine Red Alga Rhodomela confervoides, with Multi Receptor Tyrosine Kinase Inhibition Effects.FGF signaling in the developing endochondral skeleton.ephrinB1 signals from the cell surface to the nucleus by recruitment of STAT3.Urothelial tumorigenesis: a tale of divergent pathways.MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis.

P2860

14d110f1e0e2fc66d89adb3159cc4d2da5075fc0 24b1806623bef4de5e7699d9510d14e14988c4c7 b01e5a4aff5ed42d3338a481def82bc860e465a6 b636cac73d7a3761cd0f75988f4177eae49e2643 c73c845e05aa86f1fe84645ecc7839de6fc55650 da51cac008a070e184c0220813f28f51459b51b8 e08eec00e78857dbc23971efb355e90df80f0184

P248

Q24291107-22DC5D17-1A4B-40C2-87A0-4FDC33E43E7E Q24548250-D856903F-D975-45BA-93BC-980E4B5DB022 Q24794871-2254477A-397D-4609-A872-5A290E2FEE6C Q24806072-F55A964C-B0DA-46A0-97AA-10ABDB99E510 Q26772751-C5B50F24-ADDF-4A98-B189-394FB251FC5B Q26998955-286E9B72-DE31-4CCE-B3F7-510D76EE0B69 Q27698320-4CAB3EC9-D7B7-45EE-B08E-C7F5A1C2FC9D Q27824821-00AE064F-E8CA-485A-974A-089338E6FDE4 Q28066570-47AB6D32-D524-4875-9838-7F829FB01448 Q28079309-BE79A5DD-F36E-4644-A2CF-234C01A7FFF6 Q28252023-ADB55197-976B-4B0B-9875-9A9600D3CE21 Q28395997-9FED55F7-80F9-47F4-A56F-7A08F4B6E8D9 Q28508257-7E8D0108-C625-44B5-B24F-5D39CAFB44ED Q28592322-7CC8A7E7-7340-45AE-82D0-CDE93729EE51 Q28678660-8BF1DDF5-229B-4256-894C-07176BC45245 Q29614217-416B0331-EB80-4C07-B8B7-6BCC15E9D339 Q30249143-588E5E1D-464D-4CA8-B270-3AF39F82A20C Q30491274-48A53301-D696-4327-BCBB-5E6DF89480AB Q30597083-3D0F5E44-3571-4EEE-83D5-520C302F00E9 Q33273364-305CFC61-B618-4B7A-900C-F4E2BF8A7D41 Q33393633-F23D7671-7FB6-4119-8936-45DB0E1DA355 Q33751398-2E065EB4-205A-4C6A-AF37-2B6CEBB7DBC2 Q33784827-964F128A-4F38-41E1-B4D2-AD1CBB42744E Q34102786-02129C22-4CC2-4C5F-9CAD-4B50875D54BC Q34358404-F23F5D40-4E2D-4A19-B625-2DFF230104CA Q34425218-6CBAD796-0DBD-42FB-8251-77420C9C6B59 Q34467171-A6F7E286-1568-4106-9001-22424A43AA3C Q34733600-41438976-A4EE-462D-A84D-A24F37EB26AA Q34837255-A86C5193-1E05-4D5F-AC77-3E0BE8933685 Q34981278-76820B23-B8B3-40DA-8BE0-2AC611735D14 Q35014263-07A3DD39-05FE-47AF-BCC2-C78054A1328F Q35669841-9E3B1862-8796-4811-962D-41C5E29B0E99 Q35683608-442EF62D-5C61-4927-88CA-EA72B5025418 Q35814050-C384B1E1-24B3-464C-BF13-ABEC77D65A5A Q36111408-885775DB-7543-4D00-B1F9-9E89F4EEC1DA Q36141386-5AACA333-10D0-48C7-9BDE-442A76150F5F Q36234720-371DAB33-CFCF-43C3-AD4E-5826FCC55B16 Q36546530-6B9B28E1-8283-4B9A-A2B8-7F53E47999C8 Q36673626-D73B33DB-BF66-45B9-A19C-6FA5C217EC22 Q36707108-B6AF14E3-3378-4E44-8120-A65724D89EC5

P2860

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

http://www.wikidata.org/entity/Q22254704

description

2000 nî lūn-bûn

@nan

2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@ast

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@en

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@en-gb

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@nl

type

label

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@ast

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@en

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@en-gb

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@nl

prefLabel

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@ast

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@en

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@en-gb

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@nl

P1433

Q22254704-D942E148-5B36-4DA1-9AAB-B415609B7EBE

P1476

Q22254704-B65AF299-AC32-448B-BBAD-C2C8399CB462

P2093

Q22254704-37A9EA10-299E-4CF6-8A1D-3AE6F2634B2E

Q22254704-3A9CB859-141D-48E9-8CA7-3DF9D76BC501

Q22254704-6CF350B4-1D8C-44D8-A091-03348AD5A1CA

Q22254704-718BFF1D-ACFD-4807-86DA-B81C48265365

Q22254704-7E1BC96A-82B3-44A9-A1AC-B1DFF3EA7DF6

Q22254704-E6DCE735-E16B-448C-87BD-0AD5525CF43A

P2860

Q22254704-03BB8BA2-1347-4048-86A8-16067588FC66

Q22254704-0588509E-8B3E-446A-9733-7DEEF6208773

Q22254704-08611047-9F58-4CA1-AFA0-8182459060F9

Q22254704-0B84C9C8-E6CF-4C64-AE8D-41FCA7D5D3B9

Q22254704-0BBD6C08-FF6E-4499-9F5C-D16E5138F5B2

Q22254704-0D3AC356-569A-4D40-8739-93A60FA7289A

Q22254704-0FFF685D-B43E-46F9-B82F-1EB771E21B88

Q22254704-158CF841-A42D-4E5A-BCEB-28A4A64D1B98

Q22254704-1630DA78-2EF8-4E4F-94A1-A6CE595956B6

Q22254704-27832125-9BDA-45EA-89F1-E235A8ED7FB0

P2888

Q22254704-B061FD79-6CAE-49BE-90BC-B1B03C76BC85

P304

Q22254704-A5ABF4FC-D3C8-477C-948C-95A59E94B813

P31

Q22254704-33152D93-96A6-4B51-B35D-619B8F084319

P3181

Q22254704-0E033DDF-0AD0-4509-96FE-55ABFFCF9208

P356

Q22254704-BD7A1E2A-F800-450F-BBFC-BB7C589379BA

P407

Q22254704-491A0E99-B4D6-4D9E-A8FF-C4E4F66B6064

P433

Q22254704-DE814FA5-7C64-4021-9865-1FDE3345BA3C

P478

Q22254704-B72A0C20-54F2-43B9-BBA9-1420C8E1EEA2

P577

Q22254704-73A1A05B-69A3-44D3-9801-4D2720D01DF2

P5875

Q22254704-53656D16-3C07-4F08-A0CB-1F997C55000B

P6179

Q22254704-0697261D-BFB1-4F5A-AF13-89575CDB48B0

P698

Q22254704-229F6A11-980F-4286-9386-273ABF3C6512

P3181

P356

P1433

P1476

Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4

@en

P2093

A N Meyer

http://www.w3.org/2001/XMLSchema#string

D J Donoghue

http://www.w3.org/2001/XMLSchema#string

J A Tynan

http://www.w3.org/2001/XMLSchema#string

K C Hart

http://www.w3.org/2001/XMLSchema#string

M Y Kanemitsu

http://www.w3.org/2001/XMLSchema#string

S C Robertson

http://www.w3.org/2001/XMLSchema#string

P2860

Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells

A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1

Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)

Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation

Enhanced signaling and morphological transformation by a membrane-localized derivative of the fibroblast growth factor receptor 3 kinase domain

Activation and association of Stat3 with Src in v-Src-transformed cell lines

Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism

High-efficiency transformation of mammalian cells by plasmid DNA

A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3

P2888

P304

3309-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4841478

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.ONC.1203650

http://www.w3.org/2001/XMLSchema#string

P407

P433

29

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2000-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12400532

http://www.w3.org/2001/XMLSchema#string

P6179

1006401110

http://www.w3.org/2001/XMLSchema#string

P698

10918587

http://www.w3.org/2001/XMLSchema#string